A Longitudinal Study of the Impact of R&D, Patents, and Product Innovation on Firm Performance

Because of increasing levels of competition and decreasing product life cycles, a firm's ability to generate a continuous stream of innovations may be more important than ever in allowing a firm to improve profitability and maintain competitive advantage This paper investigates several issues that are central to an examination of the innovation productivity in a firm. First, the relationship between a firm's commitment to research and development and its innovative outcomes is examined. Two innovative outcomes are analyzed: (1) invention, which focuses on the development of new ideas; and (2) innovation, the development of commercially viable products or services from creative ideas. Invention is measured by the number of patents granted, and innovation is assessed by the number of new product announcements. Second, because many inventions ultimately result in marketable innovations and because patents may provide protection for new products, the relationship between patents and product announcements is also investigated. Finally, the ability of a firm to benefit from its inventions and innovations is studied by examining their separate effects on firm performance, measured as return on assets (ROA) and sales growth. Drawing from a sample of 272 firms in 35 industries over 19 years, the results from a model of simultaneous equations provided support for some of the hypotheses, but several other surprising findings were found. As expected, R&D spending was positively related to patents. This finding is consistent with others who argue that internal research capabilities, particularly those with a strong basic research component, is key to enabling a firm to generate creative outputs. More surprising was the finding of increasing returns to scale to R&D spending. While this contradicts much of the existing research, it is consistent with economic arguments for the advantages of scale in innovation. Also interesting is the finding that, while a significant curvilinear relationship exists between R&D spending and product announcements, it is not the predicted inverse-U but instead a U-shaped relationship. Consistent with previous work, product announcements were found to be positively related to both performance measures. A negative relationship was found between patents and both ROA and sales growth. While these findings were unexpected, they are intriguing and call into question the value of patents as protection mechanisms. In addition, these results may be resulting from the rise of strategic patenting, where an increasing number of firms are using patents as strategic weapons. As expected, a positive relationship was found between patents and new product announcements.

[1]  Robert E. Hoskisson,et al.  A mid-range theory of interfunctional integration, its antecedents and outcomes , 1993 .

[2]  Curtis M. Grimm,et al.  Timing, order and durability of new product advantages with imitation , 2000 .

[3]  F. Scherer,et al.  Patent Statistics as a Measure of Technical Change , 1969, Journal of Political Economy.

[4]  Z. Ács,et al.  Innovation, Market Structure, and Firm Size , 1987 .

[5]  Constance E. Helfat,et al.  The dynamic resource-based view: capability lifecycles , 2003 .

[6]  Zvi Griliches,et al.  Patents and R&D: is There a Lag? , 1984 .

[7]  Zvi Griliches,et al.  Productivity, R&D, and Basic Research at the Firm Level in the 1970s , 1985 .

[8]  A. Rai.  Fostering Cumulative Innovation in the Biopharmaceutical Industry: The Role of Patents and Antitrust , 2002 .

[9]  Robert M. Price.  Executive Forum: Technology and Strategic Advantage , 1996 .

[10]  G. Barczak.  New product strategy, structure, process, and performance in the telecommunications industry , 1995 .

[11]  Stuart Macdonald,et al.  When means become ends: considering the impact of patent strategy on innovation , 2004, Inf. Econ. Policy.

[12]  Alfredo J. Mauri,et al.  The Impact of Publishing and Patenting Activities on New Product Development and Firm Performance: The Case of the US Pharmaceutical Industry , 2003 .

[13]  Sharon Gifford,et al.  Innovation of entrepreneurial firms , 1996 .

[14]  Peter J. Sher,et al.  The effects of innovative capabilities and R&D clustering on firm performance: the evidence of Taiwan's semiconductor industry , 2005 .

[15]  Samuel B. Graves,et al.  Innovative Productivity in Pharmaceutical Firms , 1992 .

[16]  Douglas D. Moesel,et al.  The Market for Corporate Control and Firm Innovation , 1996 .

[17]  Daniel Indarto Prajogo,et al.  The relationship between innovation and business performance—a comparative study between manufacturing and service firms , 2006 .

[18]  W. Bogner,et al.  Knowledge Management as the Basis of Sustained High Performance , 2007 .

[19]  Rosanna Garcia,et al.  The Effects of Environmental Turbulence on New Product Development Strategy Planning , 2003 .

[20]  Thomas Lager,et al.  PRODUCT AND PROCESS DEVELOPMENT INTENSITY IN PROCESS INDUSTRY: A CONCEPTUAL AND EMPIRICAL ANALYSIS OF THE ALLOCATION OF COMPANY RESOURCES FOR THE DEVELOPMENT OF PROCESS TECHNOLOGY , 2002 .

[21]  V. Pucik,et al.  Relationship between innovativeness, quality, growth, profitability, and market value , 2005 .

[22]  Carine Peeters,et al.  Innovation strategy and the patenting behavior of firms , 2006 .

[23]  David B. Audretsch,et al.  Innovation in large and small firms , 1987 .

[24]  Lee Fleming,et al.  Finding the organizational sources of technological breakthroughs: the story of Hewlett‐Packard's thermal ink‐jet , 2002 .

[25]  Elizabeth J. Jensen.  Research Expenditures and the Discovery of New Drugs , 1987 .

[26]  Curba Morris Lampert,et al.  Entrepreneurship in the large corporation: a longitudinal study of how established firms create breakthrough inventions , 2001 .

[27]  A. Nerkar,et al.  Technological and product-market experience and the success of new product introductions in the pharmaceutical industry , 2004 .

[28]  Stella Y. Hua,et al.  Product Change Intensity, Product Advantage, and Market Performance: An Empirical Investigation of the PC Industry , 2006 .

[29]  Christopher A. Voss,et al.  Significant Issues for the Future of Product Innovation , 1994 .

[30]  David L. Deeds,et al.  The impact of stocks and flows of organizational knowledge on firm performance: an empirical investigation of the biotechnology industry , 1999 .

[31]  E. Mansfield.  Patents and Innovation: An Empirical Study , 1986 .

[32]  M. Hitt,et al.  The new competitive landscape , 1995 .

[33]  Geert Duysters,et al.  The Effect of Mergers and Acquisitions on the Technological Performance of Companies in a High-tech Environment , 2002, Technol. Anal. Strateg. Manag..

[34]  Steven Postrel,et al.  Shared knowledge, “glitches,” and product development performance , 1999 .

[35]  D. Encaoua,et al.  Patent Systems for Encouraging Innovation: Lessons from Economic Analysis , 2006 .

[36]  Gregory N. Stock,et al.  Building Dynamic Capabilities in New Product Development through Intertemporal Integration , 2003 .

[37]  P. Roberts.  Product innovation, product–market competition and persistent profitability in the U.S. pharmaceutical industry , 1999 .

[38]  James J. Anton,et al.  Little patents and big secrets: managing intellectual property , 2004 .

[39]  Haiyang Li,et al.  Product Innovation Strategy and the Performance of New Technology Ventures in China , 2001 .

[40]  David B. Audretsch,et al.  Innovation in Large and Small Firms: An Empirical Analysis , 1988 .

[41]  J. Shaver,et al.  Does international research and development increase patent output? An analysis of Japanese pharmaceutical firms , 2005 .

[42]  J. Hagedoorn,et al.  Measuring innovative performance: is there an advantage in using multiple indicators? , 2003 .

[43]  Wesley M. Cohen,et al.  Firm Size and the Nature of Innovation within Industries: The Case of Process and Product R&D , 1996 .

[44]  Helen Salavou,et al.  Profitability in market‐oriented SMEs: does product innovation matter? , 2002 .

[45]  Edwin Mansfield,et al.  Basic Research and Productivity Increase in Manufacturing , 1980 .

[46]  R. Nelson,et al.  Economic Theories about the Benefits and Costs of Patents , 1998 .

[47]  Cynthia A. Montgomery,et al.  Of Diamonds and Rust: A New Look at Resources , 1995 .

[48]  Samuel B. Graves,et al.  Innovative productivity and returns to scale in the pharmaceutical industry , 1993 .

[49]  R. Handfield,et al.  Supplier integration into new product development: coordinating product, process and supply chain design , 2005 .

[50]  N. Rosenberg.  Why do firms do basic research (with their own money) , 1990 .

[51]  Jeff W. Trailer,et al.  Measuring performance in entrepreneurship research , 1996 .

[52]  H. Ernst.  Patent applications and subsequent changes of performance: evidence from time-series cross-section analyses on the firm level , 2001 .

[53]  C. Greenhalgh,et al.  Running to Stand Still? – The Value of R&D, Patents and Trade Marks in Innovating Manufacturing Firms , 2005 .

[54]  A. Nerkar,et al.  Beyond local search: boundary‐spanning, exploration, and impact in the optical disk industry , 2001 .

[55]  D. B. Montgomery,et al.  First‐mover advantages , 1988 .

[56]  Edwin Mansfield,et al.  ENTRY, GIBRAT'S LAW, INNOVATION, AND THE GROWTH OF FIRMS , 1962 .

[57]  Z. Griliches,et al.  Patents and R and D: Is There a Lag? , 1986 .

[58]  J. V. Reenen,et al.  The Profitability of Innovating Firms , 1993 .

[59]  Leonard Solomon Silk,et al.  Communicating Economic Ideas and Controversies , 1986 .

[60]  Ariel Pakes,et al.  Estimates of the Value of Patent Rights in European Countries During Thepost-1950 Period , 1985 .

[61]  S. Winter,et al.  Appropriating the Returns from Industrial Research and Development , 1987 .

[62]  David B. Audretsch,et al.  The Economics of Small Firms , 1990 .

[63]  C. Hill,et al.  A longitudinal study of the cause and consequences of changes in diversification in the U.S. pharmaceutical industry 1977–1986 , 1991 .

[64]  T. Klette.  R&D, Scope Economies, and Plant Performance , 1996 .

[65]  Zvi Griliches,et al.  R&D, Patents, and Market Value Revisited: is There Evidence of a Secondtechnological Opportunity Related Factor? , 1988, Economics of Innovation and New Technology.

[66]  David B. Audretsch,et al.  Innovation and Size at the Firm Level , 1991 .

[67]  Shaker A. Zahra,et al.  New Product Innovation in Established Companies: Associations with Industry and Strategy Variables , 1994 .

[68]  V. Chiesa,et al.  Managing the internationalization of R&D activities , 1996 .

[69]  Rosemarie H. Ziedonis,et al.  The patent paradox revisited: an empirical study of patenting in the U , 2001 .

[70]  R. Katila,et al.  Technological acquisitions and the innovation performance of acquiring firms: a longitudinal study , 2001 .

[71]  Laura B. Cardinal,et al.  Internal knowledge generation: the research laboratory and innovative productivity in the pharmaceutical industry , 2000 .

[72]  Kuen‐Hung Tsai.  R&D productivity and firm size: a nonlinear examination , 2005 .

[73]  Rosemarie H. Ziedonis.  Don't Fence Me in: Fragmented Markets for Technology and the Patent Acquisition Strategies of Firms , 2003, Manag. Sci..

[74]  George M. Scott,et al.  Critical technology management issues of new product development in high-tech companies , 2000 .

[75]  Toby E. Stuart.  Interorganizational alliances and the performance of firms: A study of growth and innovation rates i , 2000 .

[76]  Raphael Amit,et al.  The Dynamics of Innovative Activity and Competitive Advantage: The Case of Australian Retail Banking, 1981 to 1995 , 2003, Organ. Sci..

[77]  M. Heller,et al.  Can Patents Deter Innovation? The Anticommons in Biomedical Research , 1998, Science.

[78]  Masayuki Kondo,et al.  R& D DYNAMICS OF CREATING PATENTS IN THE JAPANESE INDUSTRY , 1999 .

[79]  Ronald J. Mann,et al.  Patents, Venture Capital, and Software Start-Ups , 2007 .